bBright8

Activities: Marketing

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Where nanoengineering meets drug formulation How Nanexa is turning short-acting drugs into long-acting injectables
  2. MHRA approves first oral semaglutide tablet for weight loss in the UK Novo Nordisk's Wegovy tablet becomes the UK's first GLP-1 receptor agonist in oral form for obesity treatment — a significant shift in delivery format as the drug awaits NICE...
  3. ARK Invest backs Cellares to mass manufacture cell therapies with $20m investment The ARK Venture Fund has previously invested in tech platforms such as OpenAI and Anthropic and is now backing the life sciences company to solve cell therapy's scaling problem
  4. Stevanato Group launches Deora pen injector platform targeting GLP-1 and incretin therapies The fixed-dose, multi-use pull-push device accommodates volumes up to 0.75 mL, offering pharma partners a scalable, error-reducing delivery solution for diabetes and weight...
  5. UK healthcare M&A drops 26% in Q1 2026 amid geopolitical tension and financing pressures Heligan Group's latest report records just 53 deals, down from 72 in Q1 2025, with pharma and life sciences remaining most active despite tighter financing conditions and...

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all